Yangxi Xu

Yangxi Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yangxi Xu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • David Near

    McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

    1 shared publication
  • Jiandong Liu

    McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

    1 shared publication
  • Karan Ravi

    McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

    1 shared publication
  • Li Qian

    McAllister Heart Institute, University of North Carolina, Chapel Hill, NC 27599, USA

    1 shared publication
  • Li Wang

    Department of Otolaryngology, Head and Neck Surgery, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, State Key Laboratory of Virology and Biosafety, Wuhan University, Wuhan 430071, China; Department of Cardiology, Institute of Myocardial Injury and Repair, Zhongnan Hospital of Wuhan University, Wuhan 430071, China

    1 shared publication
  • Peisen Huang

    Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University

    1 shared publication

Latest Publications

  • Open Access

    Isoform Specific Effects of Mef2C during Direct Cardiac Reprogramming

    by Li Wang, Peisen Huang, David Near, Karan Ravi, Yangxi Xu, Jiandong Liu, Li Qian

    Direct conversion of cardiac fibroblasts into induced cardiomyocytes (iCMs) by forced expression of defined factors holds great potential for regenerative medicine by offering an alternative strategy for treatment of heart disease. Successful iCM conversion can be achieved by minimally using three transcription factors, Mef2c (M), Gata4(G), and Tbx5 (T). Despite increasing interest in iCM mechanistic studies using MGT(polycistronic construct with optimal expression of M,G and T), the reprogramming efficiency varies among different laboratories. Two main Mef2c isoforms (isoform2, Mi2 and isoform4, Mi4) are present in heart and are used separately by different labs, for iCM reprogramming. It is currently unknown if differently spliced isoform of Mef2c contributes to varied reprogramming efficiency. Here, we used Mi2 and Mi4 together with Gata4 and Tbx5 in separate vectors or polycistronic vector, to convert fibroblasts to iCMs. We found that Mi2 can induce higher reprogramming efficiency than Mi4 in MEFs. Addition of Hand2 to MGT retroviral cocktail or polycistronic Mi2-GT retroviruses further enhanced the iCM conversion. Overall, this study demonstrated the isoform specific effects of Mef2c, during iCM reprogramming, clarified some discrepancy about varied efficiency among labs and might lead to future research into the role of alternative splicing and the consequent variants in cell fate determination.